Today: 20 November 2025
Subscribe
Browse Category

Company News News 14 November 2025 - 16 November 2025

New Zealand Sharemarket Today: NZX 50 Slides 0.5% as Infratil Sell‑Off Caps Mainfreight Rally (13 November 2025)

New Zealand Sharemarket Today (17 November 2025): Black Pearl Returns, Comvita Deal Collapses, Warehouse Cost Reset in Focus

New Zealand’s stock market heads into Monday’s session under a cloud of caution after a sharp end‑of‑week sell‑off and a flurry of corporate announcements that could drive stock‑specific volatility through the day. On Friday, the S&P/NZX 50 Index fell 133.41 points, or 0.98%, to close at 13,464.46, with 106 decliners and just 34 gainers, as local investors followed Wall Street’s worst day in a month. Good Returns+1 Heavyweights such as Mainfreight, Infratil, Fisher & Paykel Healthcare and Meridian all eased, while smaller cap Comvita slumped after uncertainty over its takeover deal. Good Returns As of early Monday, the NZX Main
16 November 2025
 ·  ·  ·  · 
British American Tobacco (LSE: BATS) share price: what to know before the London open on 17 November 2025

British American Tobacco (LSE: BATS) share price: what to know before the London open on 17 November 2025

Summary at a glance Where BATS left off on Friday British American Tobacco shares closed at 4,072p on 14 November. BAT’s official tear‑sheet also shows the latest dividend timetable: the November instalment was paid on 7 Nov 2025 (ex‑date 2 Oct), and the next ex‑date is 29 Dec 2025 for payment on 4 Feb 2026—useful for investors positioning into year‑end. London Stock Exchange Overnight sentiment from New York is slightly softer: the ADR BTI finished Friday at $54.13. While the ADR is not a perfect predictor of the LSE open, it often provides a directional cue for early trading in
16 November 2025
 ·  ·  ·  ·  · 
CSL Limited (ASX: CSL) pre‑open brief for 17 November 2025: Buy‑back in full swing, Seqirus spin‑off delayed, guidance cut — here’s what matters

CSL Limited (ASX: CSL) pre‑open brief for 17 November 2025: Buy‑back in full swing, Seqirus spin‑off delayed, guidance cut — here’s what matters

CSL Limited heads into Monday’s open with investors still digesting a tough few months: a surprise guidance downgrade and delayed vaccines demerger at the late‑October AGM, followed by a steady drumbeat of daily buy‑back notices last week. Below is a clear, fact‑checked briefing on the latest numbers, announcements, and catalysts to watch before the bell. Where the stock last closed (Friday) The freshest company disclosures The big picture since August: restructure, guidance reset, and demerger timing Product & pipeline developments that still matter to valuation What to watch at Monday’s open 1) Follow‑through from Wall Street and sentiment reset. Friday’s
16 November 2025
 ·  ·  ·  · 
Broadcom’s AI Windfall: Inside AVGO’s Trillion-Dollar Surge, $10B Chip Deal & 2025 Outlook

Broadcom (AVGO) Stock Today, Nov 16, 2025: November News Round‑Up, AI Tailwinds, VMware Shake‑Up, and a 2026 Outlook

Updated November 16, 2025 Key takeaways AVGO price and what’s moving it now Broadcom (NASDAQ: AVGO) closed at $342.46 in the latest session (UTC), after an active week that included a brief downdraft on Thursday to the $334 area before bouncing. That move keeps the stock in a consolidating range ahead of the company’s December earnings event and follows year‑to‑date strength noted by several sell‑side desks. MarketBeat Near‑term driver: the December 11 report and call. Broadcom pre‑announced the date this week, which should concentrate positioning over the next three weeks. PR Newswire+1 November 2025: the five headlines AVGO investors must
16 November 2025
 ·  ·  ·  ·  · 
Archer Aviation (ACHR) Raises $650M, Moves to Buy Hawthorne Airport for $126M; Shares Slip After Q3 Update — Nov. 7, 2025

Archer Aviation (ACHR) Stock Today — Nov 15, 2025: $650M Share Sale, Los Angeles Airport Deal, UAE Flight Tests & What They Mean for 2026

Updated: November 15, 2025 Key takeaways What changed for ACHR in November 1) A bigger cash war chest—at a cost.On Nov. 6, Archer disclosed a $650M equity raise, executed as a registered direct sale of 81.25M shares priced at $8.00. The company’s own filings show 651.3M Class A shares outstanding at Sept. 30; the new issuance implies roughly 12.5% incremental dilution. Management says total liquidity now exceeds $2B. For a pre‑revenue aerospace program, that runway is strategically important, but the near‑term market impact has been mixed given the extra supply of shares. TradingView+2SEC+2 2) A strategic beachhead in Los Angeles.Also
15 November 2025
 ·  ·  ·  ·  · 
Boeing Scores Asia Mega-Deals Thanks to Trump – But Q3 Earnings Could Reveal a $4 Billion Shock

Boeing Stock (BA) Today, 14 November 2025: Strike Ends, Dubai Megadeal Buzz and NATO Snub Pull Shares in Opposite Directions

Boeing (NYSE: BA) is trading in a tight range today as investors digest a powerful mix of good and bad headlines: the end of a 101‑day defense strike, rumoured orders for up to 300 jets at next week’s Dubai Airshow, fresh defense and space contract wins – and a high‑profile NATO surveillance setback plus renewed concerns about cash flow. As of mid‑afternoon trading in New York on Friday, November 14, Boeing shares were hovering around $194–195, roughly flat on the day after swinging between about $192 and $197. That keeps BA well off its 52‑week high near $243, but comfortably above the year’s
14 November 2025
 ·  ·  ·  ·  · 
Warner Bros Discovery Stock Skyrockets on $60B Takeover Rumors

Warner Bros. Discovery (WBD) Stock Climbs as Paramount, Comcast and Netflix Line Up Bids in High‑Stakes Auction – November 14, 2025

Warner Bros. Discovery, Inc. (NASDAQ: WBD) moved back into the spotlight on Friday, November 14, 2025, as a potential sale of all or part of the media giant appeared to crystallize into a three‑way contest between Paramount Skydance, Comcast and Netflix. The growing prospect of a bidding war sent WBD shares higher and intensified scrutiny of the company’s strategy, leadership and balance sheet. TradingView+3Sports Business Journal+3The Wall Street Journal+3 At the same time, new regulatory and governance angles emerged: a prominent U.S. lawmaker raised antitrust concerns about a possible Netflix deal, and Warner Bros. Discovery quietly rewrote CEO David Zaslav’s
14 November 2025
 ·  ·  ·  ·  ·  ·  ·  · 
Tripadvisor (TRIP) Stock Edges Higher as Mizuho Upgrade Backs Cost Cuts, Viator Merger and AI Pivot – November 14, 2025

Tripadvisor (TRIP) Stock Edges Higher as Mizuho Upgrade Backs Cost Cuts, Viator Merger and AI Pivot – November 14, 2025

Tripadvisor, Inc. (NASDAQ: TRIP) returned to investors’ good graces on Friday after Mizuho upgraded the online travel company and lifted its price target, signaling Wall Street is starting to warm to an aggressive restructuring that includes layoffs, a Viator merger and a deeper bet on AI-powered travel experiences. Investing.com+1 As of mid‑day Friday, Tripadvisor shares were trading around $15.00, up roughly 1.5% from Thursday’s close at $14.78, though still well below their 52‑week high of $20.16. Investing.com+1 The bounce follows a bruising 6.75% slide on Thursday, when the stock sold off with the broader market despite recently reporting better‑than‑expected Q3
14 November 2025
 ·  ·  ·  ·  · 
TSS Inc. (TSSI) Stock Plunges Over 40% After Q3 2025 Earnings – AI Pivot, New Dell Veteran Director and What’s Next for 2026

TSS Inc. (TSSI) Stock Plunges Over 40% After Q3 2025 Earnings – AI Pivot, New Dell Veteran Director and What’s Next for 2026

TSS, Inc. (NASDAQ: TSSI), the AI‑focused data center systems integrator, is at the center of a dramatic market move today. Shares are trading in the high single digits this afternoon, down a little over 40% from yesterday’s close around $15.25, after investors digested a sharp Q3 2025 revenue decline, a swing to loss, and a simultaneously raised full‑year profit outlook. Finimize At the same time, TSS has deepened its AI ambitions by appointing Dell Technologies veteran Vivek Mohindra to its board of directors, drawing a wave of fresh analysis from Wall Street and independent research platforms. Stock Titan+1 Below is
14 November 2025
 ·  ·  ·  ·  · 
Aspire Biopharma (ASBP) Jumps on $100M Equity Line and Q3 Filing – What Matters on November 14, 2025

Aspire Biopharma (ASBP) Jumps on $100M Equity Line and Q3 Filing – What Matters on November 14, 2025

Micro‑cap biotech Aspire Biopharma Holdings, Inc. (NASDAQ: ASBP) is back in the spotlight today after securing a new $100 million equity line of credit and releasing its Q3 2025 10‑Q, sending the stock sharply higher in pre‑market trading. ASBP stock among Friday’s biggest pre‑market movers Aspire Biopharma shares were one of the most active health‑care names in U.S. pre‑market trade on Friday. StockTitan data places Aspire’s current market capitalization at roughly $5.3 million, with a public float of about 27.2 million shares and insider ownership above 30%. Stock Titan Today’s move comes as investors digest two major disclosures: a fresh
14 November 2025
 ·  ·  ·  ·  · 
Expion360 (XPON) Soars After Q3 2025 Earnings Beat: Revenue Up 72% as New CEO Takes the Helm

Expion360 (XPON) Soars After Q3 2025 Earnings Beat: Revenue Up 72% as New CEO Takes the Helm

Expion360 (NASDAQ: XPON) stock jumped more than 28% after hours as the lithium-ion battery maker posted a surprise Q3 2025 profit, crushed earnings estimates, and highlighted its new leadership team Quick Takeaways XPON Stock: Big After-Hours Pop, Still Deep in the Red Year-Over-Year Expion360 Inc. (NASDAQ: XPON), a maker of premium lithium iron phosphate (LiFePO₄) batteries for RV, marine and home energy storage, saw its stock jump 28.35% in after-hours trading on November 14, climbing to $1.63 after closing Thursday’s regular session at $1.27. Benzinga As of early afternoon trading on November 14, 2025, XPON is hovering around $1.27, giving
14 November 2025
 ·  ·  ·  ·  · 
Pfizer Stock Surges 15% on Trump’s Pricing Pact & $7.3B Obesity Deal – Can the Rally Last?

Pfizer Stock (PFE) Before the Bell on November 14, 2025: Metsera Deal Closes, BioNTech Stake Cut and Guidance Raised

As Wall Street heads into Friday’s session, Pfizer stock is trading slightly lower in premarket action while investors digest a trio of big developments: the completed acquisition of obesity‑drug developer Metsera, a sharp reduction in Pfizer’s stake in BioNTech, and a recent earnings report that lifted 2025 profit guidance but confirmed that COVID revenue continues to fade. Pfizer+2BioSpace+2 Benzinga’s real‑time quote shows Pfizer (NYSE: PFE) around $25.6 ahead of the U.S. market open, roughly 1% belowThursday’s close of $25.79, putting the shares on track for a mildly negative start to the day. Benzinga+1 Below is what traders and long‑term investors should know before the
14 November 2025
 ·  ·  ·  ·  ·  · 
1 … 3 4 5 6 7 … 15
Go toTop